Pharmaceuticals & Biotechnology Editor | 09/14/2011
Oliver Peter, PhD, Group Head of Drug Discovery Biology at HTS Group, Actelion Pharmaceuticals, joins Pharma IQ, to discuss compounds and biosamples and materials management.In this interview Peter covers biosample stabilisation, optimum data structures to store biosample information, challenges associated with low temperature storage and how to profit from compound management know-how.
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
SmartLab Exchange USA
April 20-21, 2026
The Logan, Philadelphia, USA
Register Now |
View Agenda |
Learn More